PARIS: The World Health Organisation recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on...
Vous n'êtes pas connecté
Paris: The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries. The new generation of appetite-suppressing drugs called GLP-1 agonists -- which include the brands Ozempic, Wegovy and Mounjaro -- have exploded in...
PARIS: The World Health Organisation recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on...
PARIS: The World Health Organisation recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on...
PARIS: The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on...
UN agency urges production of affordable generics for GLP-1 drugs to treat obesity and diabetes in developing countries.
WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and...
Weight loss jabs can slash the risk of heart patients dying or being admitted to hospital by more than half, the largest study of its kind suggests....
Weight loss jabs can slash the risk of heart patients dying or being admitted to hospital by more than half, the largest study of its kind suggests....
A partly-used, 10 gram bag of semaglutide powder made by China-based Sinopep-Allsino Biopharmaceutical, is pictured at a compounding pharmacy in...